Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2012
11/28/2012EP2527457A1 Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
11/28/2012EP2527444A2 Antisense oligonucleotide modulation of stat3 expression
11/28/2012EP2526959A1 Treatment of pulmonary disease conditions
11/28/2012EP2526194A1 Methods for intracellular delivery of nucleic acids
11/28/2012EP2525835A2 Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery
11/28/2012EP2525825A1 Combination therapy to treat autoimmune diseases
11/28/2012EP2525823A1 Delivery system for diagnostic and therapeutic agents
11/28/2012CN1738829B New 2',5'-oligoadenylic acid analog
11/28/2012CN102803493A Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBG
11/28/2012CN102803487A Cancer antigen helper peptide
11/28/2012CN102796743A Improved IL-15 and IL-15R-alpha for expression in mammalian cells
11/28/2012CN102796741A Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia
11/28/2012CN102796734A Novel target for interfering EV71 as well as small interfering RNA (Ribose Nucleic Acid) and application thereof
11/28/2012CN102796709A Liver cancer-specific gene-virus and application thereof
11/28/2012CN102796181A Peptide nucleic acid for porcine reproductive and respiratory syndrome virus and application of peptide nucleic acid
11/28/2012CN102793930A Novel bifunctional triphosphate-small interfering ribonucleic acid (3p-siRNA) for inhibiting proliferation of tumor cells and application of novel bifunctional 3p-siRNA
11/28/2012CN102793910A New application of casein kinase2-interacting protein-1 (CKIP-1) protein and coding gene thereof
11/28/2012CN102319441B Preparation method of PLGA swine influenza DNA vaccine microsphere
11/28/2012CN102240406B Method for realizing surface modification of tumor targeted nonviral vector and application thereof
11/28/2012CN102108354B siRNA with function of inhibiting replication of influenza A virus and coding sequence thereof
11/28/2012CN102094020B RNA (Ribose Nucleic Acid) interference sequence and recombined interference plasmid for inhibiting fucosyltransferase I synthesized by LeY carbohydrate antigens
11/28/2012CN102094019B RNA (Ribose Nucleic Acid) interference sequence and recombined interference plasmid for inhibiting fucosyltransferase IV synthesized by LeY carbohydrate antigens
11/28/2012CN101854918B Nucleic acid complex and nucleic acid delivery composition
11/28/2012CN101072876B Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells
11/27/2012US8318925 RNAi therapeutic for treatment of hepatitis C infection
11/27/2012US8318921 A new approach to sequence-specific silencing of a silencing target, triggered RNAi, has been developed based on the triggered hybridization of nucleic acid molecules, typically starting from monomer hairpins; detection target may be an mRNA associated with a cancer
11/27/2012US8318910 IL-13 receptor antibodies
11/27/2012US8318856 Nucleic acid delivery system comprising conjugates of PEI and hyaluronic acid
11/27/2012US8318693 Compositions and methods for inhibiting expression of mutant EGFR gene
11/27/2012US8318691 Treatment of tumors with genetically engineered herpes virus
11/27/2012US8318689 SiRNA-based cancer treatment
11/27/2012US8318688 Compositions and methods for altering RNAi
11/27/2012US8318687 Recombinant adeno-associated virus vector for treatment of Alzheimer disease
11/27/2012US8318686 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
11/27/2012US8318679 Trimerising module
11/27/2012US8318495 Hematopoietic progenitor cell gene transduction
11/27/2012US8318480 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
11/27/2012US8318463 Δ8 desaturases and their use in making polyunsaturated fatty acids
11/27/2012US8318199 Liposome for liver-specific delivery and release of therapeutic nucleic acids or drugs
11/27/2012US8318173 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits
11/27/2012US8318149 Replication competent viruses capable of silencing virus inhibitory factor expression
11/27/2012US8318148 Attenuated bacteria useful in vaccines
11/27/2012US8318137 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
11/27/2012CA2493122C Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
11/27/2012CA2461579C Porcine adenovirus e1 region
11/27/2012CA2181832C Immunization by inoculation of dna transcription unit
11/22/2012WO2012157737A1 Immunity inducing agent
11/22/2012WO2012157589A1 Cell adhesion inhibitor, cell proliferation inhibitor, and method and kit for testing cancer
11/22/2012WO2012157136A1 Rrecombinant human saposin b protein containing phosphorylated glucose ring and use thereof
11/22/2012WO2012156839A2 New generation of splice-less lentiviral vectors for safer gene therapy applications
11/22/2012WO2012156817A2 Method for treating non-small cell lung cancer
11/22/2012WO2012156747A1 Method
11/22/2012WO2012156059A1 Utilization of magnetic nanoparticles as intracellular pull-down system
11/22/2012WO2012155328A1 Composition comprising endostatin and rnai molecules and the use thereof
11/22/2012WO2012135868A3 Compositions and methods for the treatment and prevention of cardiac ischemic injury
11/22/2012WO2012118915A3 Compositions and methods for treatment of tamoxifen resistant breast cancer
11/22/2012WO2012092049A8 Brown adipocyte modification
11/22/2012WO2012045067A3 Mammalian genes involved in infection
11/22/2012US20120297493 Gene Therapy Using Transposon-Based Vectors
11/22/2012US20120295964 Retrograde transport viral vector system having envelope comprising fused glycoprotein
11/22/2012US20120295960 Treatment regimen for parkinson's disease
11/22/2012US20120295958 Modulation of glucagon receptor expression
11/22/2012US20120295950 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity
11/22/2012US20120295245 Dermal micro-organs, methods and appratuses for producing and using the same
11/22/2012US20120294944 Sustained-release nucleic acid matrix compositions
11/22/2012US20120294869 Methods for Treating Fatty Liver Disease
11/22/2012US20120294838 Regulation of endogenous gene expression in cells using zinc finger proteins
11/22/2012CA2836568A1 Immunity induction agent
11/22/2012CA2835215A1 Compositions and methods for treating retinal diseases
11/21/2012EP2524693A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability
11/21/2012EP2524039A2 Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg
11/21/2012CN102791863A Tctex-1 regulatory sequence region as stem cell marker
11/21/2012CN102791862A Treatment of insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to IRS2 and transcription factor E3 (TFE3)
11/21/2012CN102791861A Treatment of Filaggrin (FLG) related diseases by modulation of FLG expression and activity
11/21/2012CN102791859A Micro-RNA regulation in ischemia and ischemia-reperfusion injury
11/21/2012CN102791292A Delivery system for diagnostic and therapeutic agents
11/21/2012CN102787134A Self-transporter used for homologous recombination, and mucosal immune vaccine constructed thereby
11/21/2012CN102787119A Products and methods for treatment and/or prevention of virus infections
11/21/2012CN102787102A Porcine alpha interferon mature-protein recombinant adenovirus, construction method and application thereof
11/21/2012CN102787097A Modified dendritic cell and vaccine containing the same
11/21/2012CN102786695A Amphiphilic triblock copolymer, preparation method and siRNA drug carrier
11/21/2012CN102786675A Block copolymer and synthesis method thereof, and preparation method of nano particles
11/21/2012CN102786592A Specific HBV antibody
11/21/2012CN102786582A Tem8 peptides and vaccines comprising the same
11/21/2012CN102784399A Tumor suppressor gene NDRG2 based application for improving breast cancer chemotherapy sensibility
11/21/2012CN102784398A Composition comprising endostatin adopted as delivery system and chemically-synthesized RNA interference molecule, and application thereof
11/21/2012CN102784391A IL-23 and its receptor
11/21/2012CN102311956B Specific base modification antisense nucleotide chain and application thereof
11/21/2012CN102250915B Miichthys miiuy alpha chemokine gene CXCL10 as well as detection method and application thereof
11/21/2012CN102174184B Biodegradable polymer, preparation method thereof and nucleic acid drug delivery carrier
11/21/2012CN101773672B Oral biological agent for preventing and curing prawn leukopathia
11/21/2012CN101744848B Application of FHL3 (four and a half LIM domains 3) in preparation of medicines for treating tumors
11/21/2012CN101683518B Application of FHL 1 in preparing medicament for treating tumour
11/21/2012CN101580849B Dna-transfection system for generation of infectious influenza virus
11/21/2012CN101331231B Compounds and methods for peptide ribonucleic acid condensate particles for RNA therapeutics
11/20/2012US8314226 Oligonucleotide complex compositions and methods of use as gene alteration tools
11/20/2012US8314074 Formulations comprising antisense nucleotides to connexins
11/20/2012US8314067 Relatedness of human interleukin-1β convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor
11/20/2012US8313932 Polymerase inhibitor and method of using same
11/20/2012US8313927 Ucp4
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 870